Chinese patent medicine tongxinluo capsule for hypertension: A systematic review of randomised controlled trials

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Wang, Jie ^a   Xiong, Xingjiang ^a   Liu, Wei ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CHINESE DRUG; NIFEDIPINE; PLACEBO; TONGXINLUO CAPSULE; UNCLASSIFIED DRUG; VALSARTAN;

BLOATING; CHINESE MEDICINE; COUGHING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; HYPOTENSION; MEAN ARTERIAL PRESSURE; MEDICINE; MENORRHAGIA; NAUSEA; OUTCOME ASSESSMENT; PATENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN REDNESS; STOMACH PAIN; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VOMITING; WESTERN MEDICINE;

EID: 84896090667     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/187979     Document Type: Review

References (77)

1. Foster M. C., Rawlings A. M., Marrett E., Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. American Heart Journal 2013 166 1 150 156 10.1016/j.ahj.2013.03. 016
2. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. The Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
3. Picon R. V., Fuchs F. D., Moreira L. B., Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. Plos ONE 2012 7 10 1 6
4. Mittal B. V., Singh A. K., Hypertension in the developing world: challenges and opportunities. American Journal of Kidney Diseases 2010 55 3 590 598 2-s2.0-77049113202 10.1053/j.ajkd.2009.06.044
5. Yang G., Kong L., Zhao W., Wan X., Zhai Y., Chen L. C., Koplan J. P., Emergence of chronic non-communicable diseases in China. The Lancet 2008 372 9650 1697 1705 2-s2.0-55149106330 10.1016/S0140-6736(08)61366-5
6. Ma Y. Q., Mei W. H., Yin P., Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. Plos ONE 2013 8 3 1 6
7. Xiong X. J., Yang X. C., Liu W., Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 275279 10.1155/2013/275279
8. Chen G. J., Yang M. S., The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials. Plos ONE 2013 8 3 1 6 e57854
9. Xiong X. J., Yang X. C., Liu Y. M., Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertension Research 2013 36 570 579
10. Lee H., Kim S.-Y., Park J., Kim Y.-J., Lee H., Park H.-J., Acupuncture for lowering blood pressure: systematic review and meta-analysis. American Journal of Hypertension 2009 22 1 122 128 2-s2.0-57749196737 10.1038/ajh.2008.311
11. Wang J., Xiong X., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84855609561 10.1155/2012/284847 284847
12. Zheng Z., Shi H., Jia J., Li D., Lin S., A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension. Journal of the Renin-Angiotensin-Aldosterone System 2011 12 3 365 374 2-s2.0-80052390950 10.1177/1470320310391503
13. Wang J., Xiong X. J., Evidence-based Chinese medicine for hypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 12 978398 10.1155/2013/978398
14. Richard N., Complementary and alternative medicine approaches to blood pressure reduction. Canadian Family Physician 2008 54 1529 1533
15. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 2 1 5 1000113
16. Su D. J., Li L. F., Trends in the use of complementary and alternative medicine in the United States: 2002-2007. Journal of Health Care for the Poor and Underserved 2011 22 1 296 310 2-s2.0-79951658749
17. Ching S. M., Zakaria Z. A., Paimin F., Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complementary and Alternative Medicine 2013 13, article 148
18. Xu H., Chen K.-J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
19. Hawk C., Ndetan H., Evans M. W., Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of National Health Interview Survey data. Preventive Medicine 2012 54 1 18 22 2-s2.0-84855492930 10.1016/j.ypmed.2011.07.002
20. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be mainstream? Chinese Journal of Integrative Medicine 2012 18 403 404
21. Xiong X. J., Yang X. C., Liu W., Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 271462 10.1155/2012/271462
22. Nahas R., Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review. Canadian Family Physician 2008 54 11 1529 1533 2-s2.0-56549103740
23. Wang J., Xiong X. J., Liu W., Yoga for essential hypertension: a systematic review. Plos ONE 2013 8 10 6 e76357
24. Shi N. N., Han X. J., Yu W. Y., Adoption in China of clinical practice guidelines for hypertension using traditional Chinese medical approaches: a literature review based on clinical studies. The Journal of Alternative and Complementary Medicine 2013 19 1 1 8
25. Wang J., Xiong X. J., Liu W., Acupuncture for essential hypertension. International Journal of Cardiology 2013 169 5 317 326 10.1016/j.ijcard.2013.09. 001
26. Benharash P., Zhou W., Neuromodulation in treatment of hypertension by acupuncture: a neurophysiological prospective. Health 2013 5 4 65 72
27. Kim J.-I., Choi J.-Y., Lee H., Lee M. S., Ernst E., Moxibustion for hypertension: a systematic review. BMC Cardiovascular Disorders 2010 10, article 33 2-s2.0-77954172996 10.1186/1471-2261-10-33
28. Ching S. M., Zakaria Z. A., Paimin F., ASSA13-14-17 effects of Tai Chi exercises on vascular function in middle-aged and elderly women with hypertension symptom. Heart 2013 99 supplement 1 A64
29. Cheung B. M. Y., Lo J. L. F., Fong D. Y. T., Chan M. Y., Wong S. H. T., Wong V. C. W., Lam K. S. L., Lau C. P., Karlberg J. P. E., Randomised controlled trial of qigong in the treatment of mild essential hypertension. Journal of Human Hypertension 2005 19 9 697 704 2-s2.0-31044440972 10.1038/sj.jhh.1001884 (Pubitemid 43118092)
30. Lee M. S., Pittler M. H., Guo R., Ernst E., Qigong for hypertension: a systematic review of randomized clinical trials. Journal of Hypertension 2007 25 8 1525 1532 2-s2.0-34447295616 10.1097/HJH.0b013e328092ee18 (Pubitemid 47056554)
31. Liu J. X., Shang X. H., Wang G., Effect of tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997 17 7 425 428 2-s2.0-0031173483
32. Cheng Y.-T., Yang Y.-J., Zhang H.-T., Qian H.-Y., Zhao J.-L., Meng X.-M., Luo F.-L., Wu Y.-L., Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism. Chinese Medical Journal 2009 122 13 1529 1538 2-s2.0-70349556295 10.3760/cma.j.issn.0366-6999.2009.13.011
33. Xu G. C., Gao R. L., Wu Y. L., Clinical study on tongxinluo capsule in treatment of patients with angina pectoris caused by coronary heart disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997 17 7 414 416 2-s2.0-0031173434
34. You S.-J., Yang Y.-J., Chen K.-J., Gao R.-L., Wu Y.-J., Zhang J., Jing Z.-C., Bai D.-F., Wang Y.-W., Chen J.-L., The protective effects of Tong-xin-luo on myocardium and microvasculature after reperfusion in acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 2005 33 5 433 437 2-s2.0-33646200368
35. Zhang H.-T., Jia Z.-H., Zhang J., Ye Z.-K., Yang W.-X., Tian Y.-Q., Jia X., Li W., Wu Y.-L., Yang Y.-J., No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT trial). Chinese Medical Journal 2010 123 20 2858 2864 2-s2.0-79952277044 10.3760/cma.j.issn.0366-6999. 2010.20.021
36. Bu P.-L., Zhao X.-Q., Wang L.-L., Zhao Y.-X., Li C.-B., Zhang Y., Tong-xin-luo capsule inhibits left venticular remodeling in spontaneously hypertensive rats by enhancing PPAR- γ expression and suppressing NF- B activity. Chinese Medical Journal 2008 121 2 147 154 2-s2.0-39049153969 (Pubitemid 351247889)
37. Zhang C. Q., Hong L., Wang H., Effects of tongxinluo capsule on platelet activating and inflammation factors as well as vascular endothelial function in patients with essential hypertension complicated with diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010 30 4 376 379
38. Wang H. J., Xie L. D., Yao E. H., Effect of tongxinluo on myocardial fibrosis in Spontaneously Hypertensive Rats. Chinese Journal of Integrated Traditional and Western Medicine 2003 1 189 190
39. Liang J. Q., Wu K., Jia Z. H., Liu C., Ding J., Huang S. N., Yin P. P., Wu X. C., Wei C., Wu Y. L., Wang H. Y., Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/HIF-dependent signaling pathway. Journal of Ethnopharmacology 2011 133 2 517 523 2-s2.0-78651387773 10.1016/j.jep.2010.10.031
40. Higgins J. P. T., Green S., Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 2009 The Cochrane Collaboration
41. Liu F. M., Liu C. F., Clinical observation on the treatment of essential hypertension by amlodipine in combination with tongxinluo capsule. Journal of Community Medicine 2009 7 8 14 15
42. Li T., Wang S. Y., Hong J. W., The influence of tongxinluo on blood pressure and urinary albumin and the quality of life of the elderly hypertensives. Journal of Integrated Traditional and Western Medicine of Cardia-Cerebrovascular Disease 2003 1 9 552 554
43. Lu Y. G., Fu C. H., Yan H., Influence of tongxinluo on blood endothelial microparticles in patients with hypertension. Chinese Journal of Cardiovascular Rehabilitation Medicine 2012 21 6 654 657
44. Xie Z. J., The influence of tongxinluo on blood pressure of hypertension. Journal of Bethune Military Medical College 2006 4 2 101 102
45. Wei X., Chen J. Y., Influence of tongxinluo on carotid intima-media thickness (IMT) in patients with hypertension. Chinese Journal of Difficult and Complicated Cases 2009 8 5 278 279
46. Xu L. L., Guan C. Y., Wang C. Y., Influence of tongxinluo on risk factors and target organ damage in patients with hypertension. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2009 15 4 287 288
47. Zhao X. R., Cheng W. B., The influence of tongxinluo capsule on left ventricular hypertrophy (LVH) and C-reactive protein (CRP) of senile primary hypertension patients. Journal of the Jinhua Professional Technology Institute 2010 10 3 54 56
48. Xu Z., Wang L. Z., Hou Y., Effects of tongxinluo capsule on the endothelial function in essential hypertension. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2007 5 8 677 679
49. Zhu M., The curative effect of tongxinluo capsule on hypertension combined hyperuricemia. Chinese and Foreign Medical Research 2011 9 14 116
50. Rao H. P., Clinical efficacy of tongxinluo capsule in patients with essential hypertension and its effect on hemorheology. Chinese Journal of Information on TCM 2009 16 12 15 17
51. Mo Y. Q., Wu S. J., Wang Q., Clinical observation of tongxinluo capsule on hypertensive renal damage. Chinese Journal of Difficult and Complicated Cases 2009 8 11 670 672
52. Xu X. Y., Clinical observation of amlodipine combined with tongxinluo capsule on essential hypertension. Chinese Journal of Coal Industry Medicine 2005 8 5 480 482
53. Li Y. Y., Tong Y. W., Hu J., The therapeutic alliance of tongxinluo capsule and conventional antihypertensive therapy on prevention of arteriosclerosis in elderly male patient with hypertension. New Medicine 2012 43 11 768 771
54. Cheng W. J., Xi J. J., Niu Y. F., Curative effect of tongxinluo combined with losartan on hypertension complicated with hyperuricemia. China Tropical Medicine 2011 11 5 609 610
55. Wang F. L., Treating 97 cases of essential hypertension by Tongxinluo capsule plus Nifedipine retard. Journal of Practical Traditional Chinese Internal Medicine 2011 25 5 78 79
56. Chen J. F., Xu H. C., Chen X. H., Clinical observation of valsartan combined with tongxinluo in treatment of hypertension. Chinese Journal of Modern Drug 2011 5 11 68 69
57. Liao M., The curative effect of tongxinluo capsule on hypertention with renal damage. Practical Clinical Medicine 2006 7 2 19 27
58. Zhang Y., Research on the treatment of hypertensive renal damage by tongxinluo capsule. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2011 17 8 897 898
59. Yan J., He Z. J., Clinical observation of tongxinluo capsule combined with amlodipine in treatment of primary hypertension. Hebei Medicine 2007 13 12 1222 1224
60. Jiang D., Treating 38 cases of hypertension with left ventricular hypertrophy by benazepril combined with tongxinluo capsule. Henan Traditional Chinese Medicine 2011 31 10 1172 1173
61. Wang H. L., Wei D. X., Lin R. Y., Clinical observation of Tongxinluo capsule combined with nifedipine sustained release tablets in the treatment of hypertension. Chinese Journal of Clinical Healthcare 2004 7 6 425 426
62. Lu Y., Zha X. F., Treating 40 cases of hypertension with hyperviscosity by tongxinluo capsule. Journal of Practical Traditional Chinese Internal Medicine 2005 19 6 580
63. Hu J. L., The clinical effect of enalapril combined with tongxinluo in treatment of hypertensive heart disease. PJCCPVD 2013 21 6 93 94
64. Lu Y. J., Zhou M., The effect of the treatment of heart rate variability of essential hypertension by tongxinluo capsule. Prevention and Treatment of Cardio- Cerebra-L VascuLar Disease 2007 7 2 110 113
65. Zhao B., Mao Y. Y., Hu Z. G., Effect of the Tongxinluo capsule on primary hypertension. Journal of Shandong University (Health Sciences) 2007 45 8 855 857
66. Dou J., Effects of Tonx inluo on the left ven tr icular d ia stolic function in pa tien ts with hypertension and obesity. Journal of Xinxiang Medical College 2009 26 1 80 82
67. Wang Y. H., Li R. J., Zhang S. H., Effect of tongxinluo capsules combined with valsartan on hypertrophy and function of left ventricle in treating hypertension. Heibei Medicine 2010 16 10 1180 1182
68. Kjaergard L. L., Villumsen J., Gluud C., Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001 135 11 982 989 2-s2.0-0035808035 (Pubitemid 33131619)
69. Schulz K. F., Chalmers L., Hayes R. J., Altman D. G., Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995 273 5 408 412 2-s2.0-0028797790 10.1001/jama.273.5.408
70. Zhou W., Longhurst J. C., Review of trials examining the use of acupuncture to treat hypertension. Future Cardiology 2006 2 3 287 292 2-s2.0-33646539114 10.2217/14796678.2.3.287
71. Ernst E., Pittler M. H., Alternative therapy bias. Nature 1997 385 6616 480 2-s2.0-17144459432
72. Pittler M. H., Abbot N. C., Harkness E. F., Ernst E., Location bias in controlled clinical trials of complementary/alternative therapies. Journal of Clinical Epidemiology 2000 53 5 485 489 2-s2.0-0034059189 10.1016/S0895-4356(99) 00220-6 (Pubitemid 30254344)
73. Terrin N., Schmid C. H., Lau J., In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. Journal of Clinical Epidemiology 2005 58 9 894 901 2-s2.0-23644457189 10.1016/j.jclinepi. 2005.01.006 (Pubitemid 41115773)
74. Wang W., He M., Zhou M., Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma: a systematic review and meta-analysis. Plos ONE 2013 8 e84270
75. Xu H., Chen K.-J., Herb-drug interaction: an emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
76. Skalli S., Soulaymani Bencheikh R., Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Safety 2012 35 10 785 791
77. Moher D., Hopewell S., Schulz K. F., Montori V., Gøtzsche P. C., Devereaux P. J., Elbourne D., Egger M., Altman D. G., CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. British Medical Journal 2010 340 c869 2-s2.0-77950273246 10.1136/bmj.c869